{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:25:35Z","timestamp":1792290335211,"version":"4.4.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,11,12]],"date-time":"2013-11-12T00:00:00Z","timestamp":1384214400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.contraception.2013.10.018","type":"journal-article","created":{"date-parts":[[2013,11,12]],"date-time":"2013-11-12T08:10:37Z","timestamp":1384243837000},"page":"181-186","source":"Crossref","is-referenced-by-count":43,"title":["A two-pill sublingual misoprostol outpatient regimen following mifepristone for medical abortion through 70 days' LMP: a prospective comparative open-label trial"],"prefix":"10.1016","volume":"89","author":[{"given":"Hillary","family":"Bracken","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasha","family":"Dabash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Tsertsvadze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Posohova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milind","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selma","family":"Hajri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuchita","family":"Mundle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hela","family":"Chelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhouha","family":"Zeramdini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamar","family":"Tsereteli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrida","family":"Platais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverly","family":"Winikoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2013.10.018_bb0005","series-title":"Safe abortion: technical and policy guidance for health systems","author":"WHO","year":"2012"},{"key":"10.1016\/j.contraception.2013.10.018_bb0010","series-title":"Providing medical abortion in low-resource settings: an introductory guidebook","author":"Gynuity Health Projects","year":"2009"},{"key":"10.1016\/j.contraception.2013.10.018_bb0015","first-page":"871","article-title":"Clinical management guidelines of obstetrician-gynecologists: medical management of abortion","volume":"106","author":"ACOG practice bulletin","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2013.10.018_bb0020","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1097\/01.AOG.0000259319.18958.76","article-title":"Mifepristone followed in 24 hours to 48 hours by misoprostol for late first-trimester abortion","volume":"109","author":"Bracken","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2013.10.018_bb0025","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.contraception.2004.08.013","article-title":"Patient preference in a randomized study comparing medical and surgical abortion at 10\u201313 weeks gestation","volume":"71","author":"Ashok","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2013.10.018_bb0030","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/humrep\/17.1.92","article-title":"A randomized comparison of medical abortion and surgical vacuum aspiration at 10\u201313 weeks gestation","volume":"17","author":"Ashok","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2013.10.018_bb0035","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1471-0528.1999.tb08320.x","article-title":"Medical termination of pregnancy at 63 to 83 days gestation","volume":"106","author":"Gouk","year":"1999","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.contraception.2013.10.018_bb0040","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1111\/j.1471-0528.2005.00638.x","article-title":"A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation","volume":"112","author":"Hamoda","year":"2005","journal-title":"BJOG"},{"key":"10.1016\/j.contraception.2013.10.018_bb0045","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1093\/humrep\/dei037","article-title":"A randomized trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion at 13\u201320 weeks gestation","volume":"20","author":"Hamoda","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2013.10.018_bb0050","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.contraception.2004.10.015","article-title":"Medical abortion at 9\u201313 weeks' gestation: a review of 1076 consecutive cases","volume":"71","author":"Hamoda","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2013.10.018_bb0055","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1097\/AOG.0b013e31826c315f","article-title":"Extending outpatient medical abortion services through 70 days of gestational age","volume":"120","author":"Winikoff","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2013.10.018_bb0060","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJM199305273282101","article-title":"Early termination of pregnancy with mifepristone (RU 486) and the orally active prostaglandin misoprostol","volume":"328","author":"Peyron","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2013.10.018_bb0065","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0002-9378(97)70511-8","article-title":"Safety, efficacy and acceptability of medical abortion in China, Cuba and India: a comparative trial of mifepristone-misoprostol versus surgical abortion","volume":"176","author":"Winikoff","year":"1997","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.contraception.2013.10.018_bb0070","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.contraception.2012.06.011","article-title":"First-trimester medical abortion with mifepristone 200 mg and misoprostol: a systematic review","volume":"87","author":"Raymond","year":"2013","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2013.10.018_bb0075","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1586\/17474108.2.1.67","article-title":"Misoprostol for uterine evacuation in induced abortion and pregnancy failure","volume":"2","author":"Clark","year":"2007","journal-title":"Expert Rev Obstet Gynecol"},{"key":"10.1016\/j.contraception.2013.10.018_bb0080","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.contraception.2008.09.001","article-title":"Two-pill regimens of misoprostol after mifepristone medical abortion through 63 days' gestational age: a randomized controlled trial of sublingual and oral misoprostol","volume":"79","author":"Raghavan","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2013.10.018_bb0085","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1093\/humrep\/deg475","article-title":"A prospective, randomized, placebo controlled trial on the use of mifepristone with sublingual or vaginal misoprostol for medical abortions of less than 9 weeks gestation","volume":"18","author":"Tang","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2013.10.018_bb0090","article-title":"A randomized clinical trial comparing the short-term side effects of sublingual and buccal routes of misoprostol administration for medical abortions up to 63 days' gestation","author":"Chai","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2013.10.018_bb0095","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.contraception.2010.05.013","article-title":"Comparison of 400 mcg buccal and 400 mcg sublingual misoprostol after mifepristone medical abortion through 63 days' LMP: a randomized controlled trial","volume":"82","author":"Raghavan","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2013.10.018_bb0100","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.contraception.2004.06.014","article-title":"Comparison of misoprostol plasma concentrations following buccal and sublingual administration","volume":"71","author":"Schaff","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2013.10.018_bb0105","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1111\/j.1471-0528.2010.02636.x","article-title":"Misoprostol dose and route after mifepristone for early medical abortion: a randomised controlled noninferiority trial","volume":"117","author":"von Hertzen","year":"2010","journal-title":"BJOG"},{"key":"10.1016\/j.contraception.2013.10.018_bb0110","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.contraception.2011.12.012","article-title":"A randomized controlled trial of different buccal misoprostol doses in mifepristone medical abortion","volume":"86","author":"Chong","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2013.10.018_bb0115","doi-asserted-by":"crossref","first-page":"30","DOI":"10.5539\/gjhs.v4n3p30","article-title":"Termination of pregnancy in Cura\u00e7ao: need for improvement of sexual and reproductive healthcare","volume":"4","author":"Boersma","year":"2012","journal-title":"Glob J Health Sci"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782413006872?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782413006872?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,7]],"date-time":"2020-08-07T19:38:41Z","timestamp":1596829121000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782413006872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S0010782413006872"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2013.10.018","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]}}}